Injecting Mounjaro into the thigh: what the guidance actually says

The outer thigh is a licensed and commonly chosen injection site for Mounjaro's once-weekly KwikPen.
Rotating between sites, and between spots within each site, reduces the risk of injection-site reactions such as redness, bruising or lumps forming under the skin.
The needle should be inserted at a 90-degree angle into a pinched fold of skin; injection depth and technique are covered in full in your pen's Patient Information Leaflet.
Bleeding after an injection is usually minor and stops quickly — if it recurs or concerns you, your prescriber or aftercare team can advise.

The thigh is one of three licensed injection sites for Mounjaro (tirzepatide), alongside the abdomen and upper arm. NHS guidance confirms all three are clinically appropriate, and many people find the outer thigh the easiest site to reach independently, without needing a second pair of hands. Mounjaro is a prescription-only medicine; a prescriber assesses suitability before treatment begins, and the Patient Information Leaflet supplied with each pen contains the definitive injection instructions for your specific dose.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Technique, site rotation and what the clinical evidence tells us about thigh injections

What UK guidance says about where you inject Mounjaro

The Mounjaro SmPC, published on the electronic Medicines Compendium, specifies three acceptable subcutaneous injection sites: the abdomen, the outer thigh and the upper arm. All three are equally valid in clinical terms. The outer thigh is particularly popular with people who self-administer, because the area is easy to see, straightforward to pinch into a fold, and accessible without awkward positioning.

NHS tirzepatide guidance reinforces this, noting that rotating between sites is part of standard injection practice. Rotation matters not just for comfort but because repeatedly using the same small patch of skin can lead to lipohypertrophy, a build-up of fatty tissue that slows absorption and reduces the medicine's effectiveness. Moving around the thigh itself, and alternating with the abdomen or upper arm week to week, keeps tissue in good condition over the months of treatment.

One practical point worth knowing: the front and outer part of the thigh is the target zone. The inner thigh has more blood vessels and nerves close to the surface, which makes that area less comfortable and not recommended. Stay on the lateral (outer) surface, roughly midway between the knee and the top of the leg.

The evidence base behind subcutaneous injection in the thigh

Tirzepatide's clinical programme included thousands of adults across the SURMOUNT trials, with once-weekly subcutaneous dosing throughout. SURMOUNT-1, published in the New England Journal of Medicine, documented an average body-weight reduction of around 20–21% at the 15 mg dose over 72 weeks. That outcome data comes from a population using all three licensed injection sites interchangeably, meaning the thigh is as evidence-backed as any other.

Injection-site reactions were among the most reported adverse events in the trials, but the vast majority were mild: brief redness, occasional bruising, or minor itching. They were typically short-lived and rarely a reason to change sites permanently. If you want to understand the full side-effect profile before starting, our Mounjaro overview covers it in plain language alongside the efficacy data.

One question that comes up regularly among people new to self-injection is whether a little blood at the site means something has gone wrong. It usually does not. A small blood vessel at the skin's surface can occasionally be nicked by the needle; a tiny bleed is common and settles within moments with light pressure. If you are worried about bleeding after your injection, our page on whether bleeding after an injection is normal explains what to expect and when to seek advice.

Getting the practical details right

The KwikPen is designed for self-administration. Each pen contains four weekly doses, and the needle used for each injection should be changed beforehand. Used needles should never be recapped and reused; keeping a sharps container nearby makes safe disposal straightforward from day one.

Before injecting, clean the skin with an alcohol swab and allow it to dry fully — damp skin stings more and can affect how the medicine absorbs. Pinch a generous fold of skin at the outer thigh, insert the needle at 90 degrees, press the injection button and hold the pen in place for the count your leaflet specifies before withdrawing. The slow-release mechanism in the pen needs that hold time to deliver the full dose.

Storage matters more than people sometimes realise. Mounjaro is stored in the fridge, and many people keep their current pen in the fridge door next to everyday items so the routine sticks. For the exact window of time a pen may be kept at room temperature if you are travelling or away from home, the SmPC on the electronic Medicines Compendium is the definitive reference; the figure is product-specific and should come from your leaflet, not from a general source.

If you are comparing injection technique between sites, our dedicated page on where exactly to position the injection in the thigh goes deeper into landmarks and positioning. And if you are still weighing up which site suits your lifestyle best, the broader Mounjaro injection guide walks through all three sites side by side.

Pain, anxiety and making the routine sustainable

Needle anxiety is real, and our prescribers hear about it most weeks. The good news is that the KwikPen's needle is very fine and short by design, and most people report the thigh injection as far less uncomfortable than they expected. The outer thigh has fewer nerve endings close to the surface than, say, the inner arm, which is partly why it tends to feel gentler.

Injecting into cold skin can make the experience sharper. Letting the pen reach room temperature for 30 minutes before use, or warming your thigh briefly with a clean warm cloth, makes a genuine difference for many people. If pain remains a consistent concern after the first few injections, our page on whether the Mounjaro injection hurts covers technique adjustments that can help, and your prescriber is always the right person to talk to if a specific site is causing ongoing discomfort.

For a broader look at treatment costs and what private prescription includes, there is context on our Mounjaro price comparison page. And if you are still deciding whether Mounjaro is the right treatment for you, our treatment overview sets out the full picture.

If you would like a prescriber to assess your suitability and answer questions specific to your situation, you are welcome to speak to our prescribers through a free consultation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions